XML 77 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net loss $ (7,735,452) $ (6,528,082)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 2,057,638 2,485,166
Amortization of loan discount and fees 2,220,549 1,956,355
Impairment of intangible assets 600,000
Loss on extinguishment of debt 689,100
Loss on disposition of business 1,523,940
Stock-based compensation 169,262 308,511
Shares issued for services 312,634 1,656,417
Change in credit reserve (151,611) 354,282
Change in fair value of contingent consideration (10,698,475)
Discontinued operation 7,666
Non-cash lease expense 817,077
Changes in operating assets and liabilities:    
Accounts receivable, net (201,501) 153,479
Due from factor 51,153 72,220
Inventory (190,918) 514,955
Prepaid expenses and other current assets (76,637) (366,615)
Accounts payable (1,287,018) 182,242
Accrued expenses and other liabilities 477,945 1,088,763
Deferred revenue (183,782)
Accrued interest payable 106,701 326,219
Due to related parties 26,909
Lease liabilities (490,000)
Net cash used in operating activities (3,293,269) (6,457,639)
Cash flows from investing activities:    
Cash disposed (18,192)
Purchase of property, equipment and software (23,801) (27,855)
Deposits (77,280) 87,378
Net cash provided by (used in) investing activities (101,081) 41,331
Cash flows from financing activities:    
Repayments from related party advances (218,967)
Advances from factor 154,073
Issuance of loans and note payable 790,977 5,799,989
Repayments of convertible notes and loan payable (2,484,248) (8,840,092)
Insurance for common stock for cash 5,356,194
Exercise of warrants 1,167,566
Issuance of common stock in public offering 10,000,003
Offering costs (1,854,622)
Net cash provided by financing activities 3,662,923 6,207,950
Net change in cash and cash equivalents 268,573 (208,357)
Cash and cash equivalents at beginning of period 20,773 1,275,616
Cash and cash equivalents at end of period 289,346 1,067,259
Supplemental disclosure of cash flow information:    
Cash paid for income taxes
Cash paid for interest 1,684,248 1,176,305
Supplemental disclosure of non-cash investing and financing activities:    
Right of use asset 425,634 467,738
Shares issued for services and conversion of accounts payable 313,816
Conversion of preferred shares into common stock 19
Conversion of notes into preferred stock $ 5,759,177